Galilei (6420) Q4 2025 earnings summary

Executive summary

• Net sales reached ¥130.369 billion, up 12.8% year-over-year, with operating profit at ¥16.572 billion, up 8.3% year-over-year.

• Ordinary profit grew 6.3% to ¥17.175 billion year-over-year.

• Net profit attributable to owners was ¥12.008 billion, down 2.4% year-over-year due to higher corporate taxes.

• Profit attributable to owners of parent was ¥12.184 million, a slight decrease of 1.0% compared to the previous year.

• Growth was driven by strong demand in supermarkets, drug stores, and overseas markets, especially in food services.

Financial highlights

• Gross profit rose to ¥36.098 billion, up 11.4% year-over-year.

• Total assets reached ¥141.780 billion, up from ¥130.532 billion the previous year.

• Net assets increased to ¥103.509 billion, with a capital adequacy ratio of 72.5%.

• Cash flows from operating activities were ¥10.375 billion, while investing activities used ¥9.523 billion.

• Year-end cash and cash equivalents stood at ¥52.828 billion.

Outlook and guidance

• FY2026 net sales are forecast at ¥129.353 billion, a 1% decrease year-over-year.

• Operating profit is projected to decline 8.7% to ¥15.136 billion, with net profit expected at ¥10.809 billion, down 10%.

• Basic earnings per share forecast is ¥269.80 for the next fiscal year.